NCT00663611View on ClinicalTrials.gov

Growth Hormone Administration and the Human Immune System

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

October 19, 2006

Primary Completion Date

October 6, 2014

Study Completion Date

October 6, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

Norditropin

Norditropin (somatropin, rDNA origin) is a polypeptide hormone of recombinant DNA origin. The amino acid sequence of the product is identical to that of the human growth hormone of pituitary origin.

DRUG

Placebo

0.9% normal saline

Trial Locations (1)

21224

National Institute of Aging, Clinical Research Unit, Baltimore

All Listed Sponsors
lead

National Institute on Aging (NIA)

NIH

NCT00663611 - Growth Hormone Administration and the Human Immune System | Biotech Hunter | Biotech Hunter